ACCS vs PBSV: stock comparison and AI forecast
Access Newswire Inc. (ACCS) and Pharma-Bio Serv, Inc. (PBSV) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ACCS Access Newswire Inc.
- Market Cap
- $13M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
PBSV Pharma-Bio Serv, Inc.
- Price
- $0.45 -22.4% · 6M
- Market Cap
- $10M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ACCS is 1.3 times larger than PBSV by market capitalization ($13M against $10M).
- ACCS carries 0.37 times debt per unit of equity, against 0.10 times for PBSV.
- Both companies share the SEC industry classification Services-Management Consulting Services.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ACCS | PBSV |
|---|---|---|
| Market Cap | $13M | $10M |
| P/B Ratio | 0.46x | 0.99x |
| EPS | $-0.29 | $-0.01 |
| Book Value/Share | $7.64 | $0.46 |
| Revenue/Share | $5.87 | $0.41 |
| FCF/Share | $0.18 | $-0.02 |
Profitability & Margins
| Metric | ACCS | PBSV |
|---|---|---|
| ROE | – | 2.4% |
| ROA | – | 2.2% |
| ROIC | -6.4% | -1.5% |
| Gross Margin | 74.9% | 32.3% |
| Operating Margin | -8.8% | -1.6% |
| Net Margin | – | 2.6% |
| EBT Margin | -8.0% | 2.8% |
| Tax Rate | 15.0% | 2.9% |
Financial Health
| Metric | ACCS | PBSV |
|---|---|---|
| Current Ratio | 0.82x | 11.30x |
| D/E Ratio | 0.37x | 0.10x |
| Financial Leverage | 1.37x | 1.10x |
| Interest Coverage | -8.3x | 479.7x |
| Working Capital | -$2M | $10M |
Cash Flow
| Metric | ACCS | PBSV |
|---|---|---|
| Operating Cash Flow | $720K | -$410K |
| Free Cash Flow | $690K | -$420K |
| Capital Spending | -$30K | -$10K |
| OCF Growth YoY | -77.8% | – |
| FCF Growth YoY | -78.6% | – |
| FCF/Sales | 3.1% | -4.4% |
| CapEx/Sales | 0.1% | 0.1% |
Operational Efficiency
| Metric | ACCS | PBSV |
|---|---|---|
| Asset Turnover | 0.56x | 0.83x |
| Receivables Turnover | 6.5x | 3.9x |
| Fixed Assets Turnover | 218.1x | 118.5x |
| Days Sales Outstanding | 56 days | 93 days |
| Payables Period | 101 days | 53 days |
Income Statement
| Metric | ACCS | PBSV |
|---|---|---|
| Total Revenue | $22M | $9M |
| Operating Income | -$2M | -$150K |
| Net Income | – | $250K |
| R&D Expense | $2M | – |
| SG&A Expense | $15M | $3M |
| Cost of Goods Sold | $6M | $6M |
Dividend & Shareholder Information
| Metric | ACCS | PBSV |
|---|---|---|
| Shares Outstanding | 4M | 23M |
ACCS vs PBSV: stock comparison and AI forecast
Which is bigger, ACCS or PBSV?
ACCS is 1.3 times larger than PBSV by market capitalization ($13M against $10M).
Which one does Intratio's AI model rank higher, ACCS or PBSV?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.